How big is the mrna synthesis service market?

Q: How big is the mrna synthesis service market?

Market Analysis and Insights Global mRNA Synthesis Service MarketThe global mRNA Synthesis Service market size is projected to reach US million by 2028 from US million in 2021 at a CAGR of during 20222028.Fully considering the economic change by this health crisis mRNA Vaccine Synthesis accounting for of the mRNA Synthesis Service global market in 2021 is projected to value US million by 2028 growing at a revised CAGR from 2022 to 2028.

BUY CHAPTERS

Global mRNA Synthesis Service Market Research Report 2022

Code: QYRE-Auto-7A11464

Report

2022-07-05

Pages:111

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

ApexBio

Takeda Pharmaceuticals

Tesla

Thermo Fisher Scientific

VGXI

Wacker Chemie

Siegfried

ST Pharm

Novartis

Novo Nordisk

Pfizer Inc

LakePharma

Lion TCR

Lonza

Merck

GlaxoSmithKline PLC

GenePharma

Fareva

Fosun Pharma

GC Pharma

Syneos Health

Bayer

Eli Lilly

Beijing Tricision Biotherapeutics

Cellerna

CMC Pharmaceuticals

Market Analysis and Insights: Global mRNA Synthesis Service Market

The global mRNA Synthesis Service market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, mRNA Vaccine Synthesis accounting for % of the mRNA Synthesis Service global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028.

While Clinical segment is altered to an % CAGR throughout this forecast period.

China mRNA Synthesis Service market size is valued at US$ million in 2021, while the North America and Europe mRNA Synthesis Service are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe mRNA Synthesis Service landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global mRNA Synthesis Service market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global mRNA Synthesis Service market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global mRNA Synthesis Service market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global mRNA Synthesis Service market.

Global mRNA Synthesis Service Scope and Market Size

mRNA Synthesis Service market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global mRNA Synthesis Service market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

mRNA Vaccine Synthesis

mRNA Drug Synthesis

Segment by Application

Clinical

Research

Others

BY REGION

North America

United States

Canada

Europe

Germany

France

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

BY COMPANY

APExBIO

Takeda Pharmaceuticals

Tesla

Thermo Fisher Scientific

VGXI

WACKER Chemie

Siegfried

ST Pharm

Novartis

Novo Nordisk

Pfizer

LakePharma

Lion TCR

Lonza

Merck

GlaxoSmithKline

GenePharma

Fareva

Fosun Pharma

GC Pharma

Syneos Health

Bayer

Beijing Tricision Biotherapeutics

Cellerna

Eli Lilly

CMC Pharmaceuticals

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global mRNA Synthesis Service Market Size Growth Rate by Type: 2017 VS 2021 VS 2028

1.2.2 mRNA Vaccine Synthesis

1.2.3 mRNA Drug Synthesis

1.3 Market by Application

1.3.1 Global mRNA Synthesis Service Market Share by Application: 2017 VS 2021 VS 2028

1.3.2 Clinical

1.3.3 Research

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global mRNA Synthesis Service Market Perspective (2017-2028)

2.2 mRNA Synthesis Service Growth Trends by Region

2.2.1 mRNA Synthesis Service Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 mRNA Synthesis Service Historic Market Size by Region (2017-2022)

2.2.3 mRNA Synthesis Service Forecasted Market Size by Region (2023-2028)

2.3 mRNA Synthesis Service Market Dynamics

2.3.1 mRNA Synthesis Service Industry Trends

2.3.2 mRNA Synthesis Service Market Drivers

2.3.3 mRNA Synthesis Service Market Challenges

2.3.4 mRNA Synthesis Service Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top mRNA Synthesis Service Players by Revenue

3.1.1 Global Top mRNA Synthesis Service Players by Revenue (2017-2022)

3.1.2 Global mRNA Synthesis Service Revenue Market Share by Players (2017-2022)

3.2 Global mRNA Synthesis Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by mRNA Synthesis Service Revenue

3.4 Global mRNA Synthesis Service Market Concentration Ratio

3.4.1 Global mRNA Synthesis Service Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by mRNA Synthesis Service Revenue in 2021

3.5 mRNA Synthesis Service Key Players Head office and Area Served

3.6 Key Players mRNA Synthesis Service Product Solution and Service

3.7 Date of Enter into mRNA Synthesis Service Market

3.8 Mergers & Acquisitions, Expansion Plans

4 mRNA Synthesis Service Breakdown Data by Type

4.1 Global mRNA Synthesis Service Historic Market Size by Type (2017-2022)

4.2 Global mRNA Synthesis Service Forecasted Market Size by Type (2023-2028)

5 mRNA Synthesis Service Breakdown Data by Application

5.1 Global mRNA Synthesis Service Historic Market Size by Application (2017-2022)

5.2 Global mRNA Synthesis Service Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America mRNA Synthesis Service Market Size (2017-2028)

6.2 North America mRNA Synthesis Service Market Size by Country (2017-2022)

6.3 North America mRNA Synthesis Service Market Size by Country (2023-2028)

6.4 United States

6.5 Canada

7 Europe

7.1 Europe mRNA Synthesis Service Market Size (2017-2028)

7.2 Europe mRNA Synthesis Service Market Size by Country (2017-2022)

7.3 Europe mRNA Synthesis Service Market Size by Country (2023-2028)

7.4 Germany

7.5 France

7.6 U.K.

7.7 Italy

7.8 Russia

7.9 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific mRNA Synthesis Service Market Size (2017-2028)

8.2 Asia-Pacific mRNA Synthesis Service Market Size by Country (2017-2022)

8.3 Asia-Pacific mRNA Synthesis Service Market Size by Country (2023-2028)

8.4 China

8.5 Japan

8.6 South Korea

8.7 Southeast Asia

8.8 India

8.9 Australia

9 Latin America

9.1 Latin America mRNA Synthesis Service Market Size (2017-2028)

9.2 Latin America mRNA Synthesis Service Market Size by Country (2017-2022)

9.3 Latin America mRNA Synthesis Service Market Size by Country (2023-2028)

9.4 Mexico

9.5 Brazil

10 Middle East & Africa

10.1 Middle East & Africa mRNA Synthesis Service Market Size (2017-2028)

10.2 Middle East & Africa mRNA Synthesis Service Market Size by Country (2017-2022)

10.3 Middle East & Africa mRNA Synthesis Service Market Size by Country (2023-2028)

10.4 Turkey

10.5 Saudi Arabia

10.6 UAE

11 Key Players Profiles

11.1 APExBIO

11.1.1 APExBIO Company Detail

11.1.2 APExBIO Business Overview

11.1.3 APExBIO mRNA Synthesis Service Introduction

11.1.4 APExBIO Revenue in mRNA Synthesis Service Business (2017-2022)

11.1.5 APExBIO Recent Development

11.2 Takeda Pharmaceuticals

11.2.1 Takeda Pharmaceuticals Company Detail

11.2.2 Takeda Pharmaceuticals Business Overview

11.2.3 Takeda Pharmaceuticals mRNA Synthesis Service Introduction

11.2.4 Takeda Pharmaceuticals Revenue in mRNA Synthesis Service Business (2017-2022)

11.2.5 Takeda Pharmaceuticals Recent Development

11.3 Tesla

11.3.1 Tesla Company Detail

11.3.2 Tesla Business Overview

11.3.3 Tesla mRNA Synthesis Service Introduction

11.3.4 Tesla Revenue in mRNA Synthesis Service Business (2017-2022)

11.3.5 Tesla Recent Development

11.4 Thermo Fisher Scientific

11.4.1 Thermo Fisher Scientific Company Detail

11.4.2 Thermo Fisher Scientific Business Overview

11.4.3 Thermo Fisher Scientific mRNA Synthesis Service Introduction

11.4.4 Thermo Fisher Scientific Revenue in mRNA Synthesis Service Business (2017-2022)

11.4.5 Thermo Fisher Scientific Recent Development

11.5 VGXI

11.5.1 VGXI Company Detail

11.5.2 VGXI Business Overview

11.5.3 VGXI mRNA Synthesis Service Introduction

11.5.4 VGXI Revenue in mRNA Synthesis Service Business (2017-2022)

11.5.5 VGXI Recent Development

11.6 WACKER Chemie

11.6.1 WACKER Chemie Company Detail

11.6.2 WACKER Chemie Business Overview

11.6.3 WACKER Chemie mRNA Synthesis Service Introduction

11.6.4 WACKER Chemie Revenue in mRNA Synthesis Service Business (2017-2022)

11.6.5 WACKER Chemie Recent Development

11.7 Siegfried

11.7.1 Siegfried Company Detail

11.7.2 Siegfried Business Overview

11.7.3 Siegfried mRNA Synthesis Service Introduction

11.7.4 Siegfried Revenue in mRNA Synthesis Service Business (2017-2022)

11.7.5 Siegfried Recent Development

11.8 ST Pharm

11.8.1 ST Pharm Company Detail

11.8.2 ST Pharm Business Overview

11.8.3 ST Pharm mRNA Synthesis Service Introduction

11.8.4 ST Pharm Revenue in mRNA Synthesis Service Business (2017-2022)

11.8.5 ST Pharm Recent Development

11.9 Novartis

11.9.1 Novartis Company Detail

11.9.2 Novartis Business Overview

11.9.3 Novartis mRNA Synthesis Service Introduction

11.9.4 Novartis Revenue in mRNA Synthesis Service Business (2017-2022)

11.9.5 Novartis Recent Development

11.10 Novo Nordisk

11.10.1 Novo Nordisk Company Detail

11.10.2 Novo Nordisk Business Overview

11.10.3 Novo Nordisk mRNA Synthesis Service Introduction

11.10.4 Novo Nordisk Revenue in mRNA Synthesis Service Business (2017-2022)

11.10.5 Novo Nordisk Recent Development

11.11 Pfizer

11.11.1 Pfizer Company Detail

11.11.2 Pfizer Business Overview

11.11.3 Pfizer mRNA Synthesis Service Introduction

11.11.4 Pfizer Revenue in mRNA Synthesis Service Business (2017-2022)

11.11.5 Pfizer Recent Development

11.12 LakePharma

11.12.1 LakePharma Company Detail

11.12.2 LakePharma Business Overview

11.12.3 LakePharma mRNA Synthesis Service Introduction

11.12.4 LakePharma Revenue in mRNA Synthesis Service Business (2017-2022)

11.12.5 LakePharma Recent Development

11.13 Lion TCR

11.13.1 Lion TCR Company Detail

11.13.2 Lion TCR Business Overview

11.13.3 Lion TCR mRNA Synthesis Service Introduction

11.13.4 Lion TCR Revenue in mRNA Synthesis Service Business (2017-2022)

11.13.5 Lion TCR Recent Development

11.14 Lonza

11.14.1 Lonza Company Detail

11.14.2 Lonza Business Overview

11.14.3 Lonza mRNA Synthesis Service Introduction

11.14.4 Lonza Revenue in mRNA Synthesis Service Business (2017-2022)

11.14.5 Lonza Recent Development

11.15 Merck

11.15.1 Merck Company Detail

11.15.2 Merck Business Overview

11.15.3 Merck mRNA Synthesis Service Introduction

11.15.4 Merck Revenue in mRNA Synthesis Service Business (2017-2022)

11.15.5 Merck Recent Development

11.16 GlaxoSmithKline

11.16.1 GlaxoSmithKline Company Detail

11.16.2 GlaxoSmithKline Business Overview

11.16.3 GlaxoSmithKline mRNA Synthesis Service Introduction

11.16.4 GlaxoSmithKline Revenue in mRNA Synthesis Service Business (2017-2022)

11.16.5 GlaxoSmithKline Recent Development

11.17 GenePharma

11.17.1 GenePharma Company Detail

11.17.2 GenePharma Business Overview

11.17.3 GenePharma mRNA Synthesis Service Introduction

11.17.4 GenePharma Revenue in mRNA Synthesis Service Business (2017-2022)

11.17.5 GenePharma Recent Development

11.18 Fareva

11.18.1 Fareva Company Detail

11.18.2 Fareva Business Overview

11.18.3 Fareva mRNA Synthesis Service Introduction

11.18.4 Fareva Revenue in mRNA Synthesis Service Business (2017-2022)

11.18.5 Fareva Recent Development

11.19 Fosun Pharma

11.19.1 Fosun Pharma Company Detail

11.19.2 Fosun Pharma Business Overview

11.19.3 Fosun Pharma mRNA Synthesis Service Introduction

11.19.4 Fosun Pharma Revenue in mRNA Synthesis Service Business (2017-2022)

11.19.5 Fosun Pharma Recent Development

11.20 GC Pharma

11.20.1 GC Pharma Company Detail

11.20.2 GC Pharma Business Overview

11.20.3 GC Pharma mRNA Synthesis Service Introduction

11.20.4 GC Pharma Revenue in mRNA Synthesis Service Business (2017-2022)

11.20.5 GC Pharma Recent Development

11.21 Syneos Health

11.21.1 Syneos Health Company Detail

11.21.2 Syneos Health Business Overview

11.21.3 Syneos Health mRNA Synthesis Service Introduction

11.21.4 Syneos Health Revenue in mRNA Synthesis Service Business (2017-2022)

11.21.5 Syneos Health Recent Development

11.22 Bayer

11.22.1 Bayer Company Detail

11.22.2 Bayer Business Overview

11.22.3 Bayer mRNA Synthesis Service Introduction

11.22.4 Bayer Revenue in mRNA Synthesis Service Business (2017-2022)

11.22.5 Bayer Recent Development

11.23 Beijing Tricision Biotherapeutics

11.23.1 Beijing Tricision Biotherapeutics Company Detail

11.23.2 Beijing Tricision Biotherapeutics Business Overview

11.23.3 Beijing Tricision Biotherapeutics mRNA Synthesis Service Introduction

11.23.4 Beijing Tricision Biotherapeutics Revenue in mRNA Synthesis Service Business (2017-2022)

11.23.5 Beijing Tricision Biotherapeutics Recent Development

11.24 Cellerna

11.24.1 Cellerna Company Detail

11.24.2 Cellerna Business Overview

11.24.3 Cellerna mRNA Synthesis Service Introduction

11.24.4 Cellerna Revenue in mRNA Synthesis Service Business (2017-2022)

11.24.5 Cellerna Recent Development

11.25 Eli Lilly

11.25.1 Eli Lilly Company Detail

11.25.2 Eli Lilly Business Overview

11.25.3 Eli Lilly mRNA Synthesis Service Introduction

11.25.4 Eli Lilly Revenue in mRNA Synthesis Service Business (2017-2022)

11.25.5 Eli Lilly Recent Development

11.26 CMC Pharmaceuticals

11.26.1 CMC Pharmaceuticals Company Detail

11.26.2 CMC Pharmaceuticals Business Overview

11.26.3 CMC Pharmaceuticals mRNA Synthesis Service Introduction

11.26.4 CMC Pharmaceuticals Revenue in mRNA Synthesis Service Business (2017-2022)

11.26.5 CMC Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

ApexBio

Takeda Pharmaceuticals

Tesla

Thermo Fisher Scientific

VGXI

Wacker Chemie

Siegfried

ST Pharm

Novartis

Novo Nordisk

Pfizer Inc

LakePharma

Lion TCR

Lonza

Merck

GlaxoSmithKline PLC

GenePharma

Fareva

Fosun Pharma

GC Pharma

Syneos Health

Bayer

Eli Lilly

Beijing Tricision Biotherapeutics

Cellerna

CMC Pharmaceuticals

List of Tables

Table 1. Global mRNA Synthesis Service Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028

Table 2. Key Players of mRNA Vaccine Synthesis

Table 3. Key Players of mRNA Drug Synthesis

Table 4. Global mRNA Synthesis Service Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028

Table 5. Global mRNA Synthesis Service Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

Table 6. Global mRNA Synthesis Service Market Size by Region (2017-2022) & (US$ Million)

Table 7. Global mRNA Synthesis Service Market Share by Region (2017-2022)

Table 8. Global mRNA Synthesis Service Forecasted Market Size by Region (2023-2028) & (US$ Million)

Table 9. Global mRNA Synthesis Service Market Share by Region (2023-2028)

Table 10. mRNA Synthesis Service Market Trends

Table 11. mRNA Synthesis Service Market Drivers

Table 12. mRNA Synthesis Service Market Challenges

Table 13. mRNA Synthesis Service Market Restraints

Table 14. Global mRNA Synthesis Service Revenue by Players (2017-2022) & (US$ Million)

Table 15. Global mRNA Synthesis Service Market Share by Players (2017-2022)

Table 16. Global Top mRNA Synthesis Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Synthesis Service as of 2021)

Table 17. Ranking of Global Top mRNA Synthesis Service Companies by Revenue (US$ Million) in 2021

Table 18. Global 5 Largest Players Market Share by mRNA Synthesis Service Revenue (CR5 and HHI) & (2017-2022)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players mRNA Synthesis Service Product Solution and Service

Table 21. Date of Enter into mRNA Synthesis Service Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global mRNA Synthesis Service Market Size by Type (2017-2022) & (US$ Million)

Table 24. Global mRNA Synthesis Service Revenue Market Share by Type (2017-2022)

Table 25. Global mRNA Synthesis Service Forecasted Market Size by Type (2023-2028) & (US$ Million)

Table 26. Global mRNA Synthesis Service Revenue Market Share by Type (2023-2028)

Table 27. Global mRNA Synthesis Service Market Size by Application (2017-2022) & (US$ Million)

Table 28. Global mRNA Synthesis Service Revenue Market Share by Application (2017-2022)

Table 29. Global mRNA Synthesis Service Forecasted Market Size by Application (2023-2028) & (US$ Million)

Table 30. Global mRNA Synthesis Service Revenue Market Share by Application (2023-2028)

Table 31. North America mRNA Synthesis Service Market Size by Country (2017-2022) & (US$ Million)

Table 32. North America mRNA Synthesis Service Market Size by Country (2023-2028) & (US$ Million)

Table 33. Europe mRNA Synthesis Service Market Size by Country (2017-2022) & (US$ Million)

Table 34. Europe mRNA Synthesis Service Market Size by Country (2023-2028) & (US$ Million)

Table 35. Asia-Pacific mRNA Synthesis Service Market Size by Region (2017-2022) & (US$ Million)

Table 36. Asia-Pacific mRNA Synthesis Service Market Size by Region (2023-2028) & (US$ Million)

Table 37. Latin America mRNA Synthesis Service Market Size by Country (2017-2022) & (US$ Million)

Table 38. Latin America mRNA Synthesis Service Market Size by Country (2023-2028) & (US$ Million)

Table 39. Middle East & Africa mRNA Synthesis Service Market Size by Country (2017-2022) & (US$ Million)

Table 40. Middle East & Africa mRNA Synthesis Service Market Size by Country (2023-2028) & (US$ Million)

Table 41. APExBIO Company Detail

Table 42. APExBIO Business Overview

Table 43. APExBIO mRNA Synthesis Service Product

Table 44. APExBIO Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)

Table 45. APExBIO Recent Development

Table 46. Takeda Pharmaceuticals Company Detail

Table 47. Takeda Pharmaceuticals Business Overview

Table 48. Takeda Pharmaceuticals mRNA Synthesis Service Product

Table 49. Takeda Pharmaceuticals Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)

Table 50. Takeda Pharmaceuticals Recent Development

Table 51. Tesla Company Detail

Table 52. Tesla Business Overview

Table 53. Tesla mRNA Synthesis Service Product

Table 54. Tesla Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)

Table 55. Tesla Recent Development

Table 56. Thermo Fisher Scientific Company Detail

Table 57. Thermo Fisher Scientific Business Overview

Table 58. Thermo Fisher Scientific mRNA Synthesis Service Product

Table 59. Thermo Fisher Scientific Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)

Table 60. Thermo Fisher Scientific Recent Development

Table 61. VGXI Company Detail

Table 62. VGXI Business Overview

Table 63. VGXI mRNA Synthesis Service Product

Table 64. VGXI Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)

Table 65. VGXI Recent Development

Table 66. WACKER Chemie Company Detail

Table 67. WACKER Chemie Business Overview

Table 68. WACKER Chemie mRNA Synthesis Service Product

Table 69. WACKER Chemie Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)

Table 70. WACKER Chemie Recent Development

Table 71. Siegfried Company Detail

Table 72. Siegfried Business Overview

Table 73. Siegfried mRNA Synthesis Service Product

Table 74. Siegfried Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)

Table 75. Siegfried Recent Development

Table 76. ST Pharm Company Detail

Table 77. ST Pharm Business Overview

Table 78. ST Pharm mRNA Synthesis Service Product

Table 79. ST Pharm Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)

Table 80. ST Pharm Recent Development

Table 81. Novartis Company Detail

Table 82. Novartis Business Overview

Table 83. Novartis mRNA Synthesis Service Product

Table 84. Novartis Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)

Table 85. Novartis Recent Development

Table 86. Novo Nordisk Company Detail

Table 87. Novo Nordisk Business Overview

Table 88. Novo Nordisk mRNA Synthesis Service Product

Table 89. Novo Nordisk Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)

Table 90. Novo Nordisk Recent Development

Table 91. Pfizer Company Detail

Table 92. Pfizer Business Overview

Table 93. Pfizer mRNA Synthesis ServiceProduct

Table 94. Pfizer Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)

Table 95. Pfizer Recent Development

Table 96. LakePharma Company Detail

Table 97. LakePharma Business Overview

Table 98. LakePharma mRNA Synthesis ServiceProduct

Table 99. LakePharma Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)

Table 100. LakePharma Recent Development

Table 101. Lion TCR Company Detail

Table 102. Lion TCR Business Overview

Table 103. Lion TCR mRNA Synthesis ServiceProduct

Table 104. Lion TCR Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)

Table 105. Lion TCR Recent Development

Table 106. Lonza Company Detail

Table 107. Lonza Business Overview

Table 108. Lonza mRNA Synthesis ServiceProduct

Table 109. Lonza Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)

Table 110. Lonza Recent Development

Table 111. Merck Company Detail

Table 112. Merck Business Overview

Table 113. Merck mRNA Synthesis ServiceProduct

Table 114. Merck Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)

Table 115. Merck Recent Development

Table 116. GlaxoSmithKline Company Detail

Table 117. GlaxoSmithKline Business Overview

Table 118. GlaxoSmithKline mRNA Synthesis ServiceProduct

Table 119. GlaxoSmithKline Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)

Table 120. GlaxoSmithKline Recent Development

Table 121. GenePharma Company Detail

Table 122. GenePharma Business Overview

Table 123. GenePharma mRNA Synthesis ServiceProduct

Table 124. GenePharma Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)

Table 125. GenePharma Recent Development

Table 126. Fareva Company Detail

Table 127. Fareva Business Overview

Table 128. Fareva mRNA Synthesis ServiceProduct

Table 129. Fareva Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)

Table 130. Fareva Recent Development

Table 131. Fosun Pharma Company Detail

Table 132. Fosun Pharma Business Overview

Table 133. Fosun Pharma mRNA Synthesis ServiceProduct

Table 134. Fosun Pharma Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)

Table 135. Fosun Pharma Recent Development

Table 136. GC Pharma Company Detail

Table 137. GC Pharma Business Overview

Table 138. GC Pharma mRNA Synthesis ServiceProduct

Table 139. GC Pharma Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)

Table 140. GC Pharma Recent Development

Table 141. Syneos Health Company Detail

Table 142. Syneos Health Business Overview

Table 143. Syneos Health mRNA Synthesis ServiceProduct

Table 144. Syneos Health Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)

Table 145. Syneos Health Recent Development

Table 146. Bayer Company Detail

Table 147. Bayer Business Overview

Table 148. Bayer mRNA Synthesis ServiceProduct

Table 149. Bayer Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)

Table 150. Bayer Recent Development

Table 151. Beijing Tricision Biotherapeutics Company Detail

Table 152. Beijing Tricision Biotherapeutics Business Overview

Table 153. Beijing Tricision Biotherapeutics mRNA Synthesis ServiceProduct

Table 154. Beijing Tricision Biotherapeutics Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)

Table 155. Beijing Tricision Biotherapeutics Recent Development

Table 156. Cellerna Company Detail

Table 157. Cellerna Business Overview

Table 158. Cellerna mRNA Synthesis ServiceProduct

Table 159. Cellerna Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)

Table 160. Cellerna Recent Development

Table 161. Eli Lilly Company Detail

Table 162. Eli Lilly Business Overview

Table 163. Eli Lilly mRNA Synthesis ServiceProduct

Table 164. Eli Lilly Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)

Table 165. Eli Lilly Recent Development

Table 166. CMC Pharmaceuticals Company Detail

Table 167. CMC Pharmaceuticals Business Overview

Table 168. CMC Pharmaceuticals mRNA Synthesis ServiceProduct

Table 169. CMC Pharmaceuticals Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)

Table 170. CMC Pharmaceuticals Recent Development

Table 171. Research Programs/Design for This Report

Table 172. Key Data Information from Secondary Sources

Table 173. Key Data Information from Primary Sources

List of Figures

Figure 1. Global mRNA Synthesis Service Market Share by Type: 2021 VS 2028

Figure 2. mRNA Vaccine Synthesis Features

Figure 3. mRNA Drug Synthesis Features

Figure 4. Global mRNA Synthesis Service Market Share by Application in 2021 & 2028

Figure 5. Clinical Case Studies

Figure 6. Research Case Studies

Figure 7. Others Case Studies

Figure 8. mRNA Synthesis Service Report Years Considered

Figure 9. Global mRNA Synthesis Service Market Size (US$ Million), Year-over-Year: 2017-2028

Figure 10. Global mRNA Synthesis Service Market Size, (US$ Million), 2017 VS 2021 VS 2028

Figure 11. Global mRNA Synthesis Service Market Share by Region: 2021 VS 2028

Figure 12. Global mRNA Synthesis Service Market Share by Players in 2021

Figure 13. Global Top mRNA Synthesis Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Synthesis Service as of 2021)

Figure 14. The Top 10 and 5 Players Market Share by mRNA Synthesis Service Revenue in 2021

Figure 15. North America mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 16. North America mRNA Synthesis Service Market Share by Country (2017-2028)

Figure 17. United States mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 18. Canada mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 19. Europe mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 20. Europe mRNA Synthesis Service Market Share by Country (2017-2028)

Figure 21. Germany mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 22. France mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 23. U.K. mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 24. Italy mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 25. Russia mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 26. Nordic Countries mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 27. Asia-Pacific mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 28. Asia-Pacific mRNA Synthesis Service Market Share by Region (2017-2028)

Figure 29. China mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 30. Japan mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 31. South Korea mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 32. Southeast Asia mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 33. India mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 34. Australia mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 35. Latin America mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 36. Latin America mRNA Synthesis Service Market Share by Country (2017-2028)

Figure 37. Mexico mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 38. Brazil mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 39. Middle East & Africa mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 40. Middle East & Africa mRNA Synthesis Service Market Share by Country (2017-2028)

Figure 41. Turkey mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 42. Saudi Arabia mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 43. APExBIO Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)

Figure 44. Takeda Pharmaceuticals Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)

Figure 45. Tesla Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)

Figure 46. Thermo Fisher Scientific Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)

Figure 47. VGXI Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)

Figure 48. WACKER Chemie Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)

Figure 49. Siegfried Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)

Figure 50. ST Pharm Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)

Figure 51. Novartis Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)

Figure 52. Novo Nordisk Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)

Figure 53. Pfizer Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)

Figure 54. LakePharma Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)

Figure 55. Lion TCR Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)

Figure 56. Lonza Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)

Figure 57. Merck Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)

Figure 58. GlaxoSmithKline Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)

Figure 59. GenePharma Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)

Figure 60. Fareva Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)

Figure 61. Fosun Pharma Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)

Figure 62. GC Pharma Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)

Figure 63. Syneos Health Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)

Figure 64. Bayer Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)

Figure 65. Beijing Tricision Biotherapeutics Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)

Figure 66. Cellerna Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)

Figure 67. Eli Lilly Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)

Figure 68. CMC Pharmaceuticals Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Global mRNA Synthesis Service Market Research Report 2022

Published Date: 2022-07-05

Report Code: QYRE-Auto-7A11464

Global mRNA Synthesis Service Market Research Report 2022

FEATURED COMPANIES

Segment by Type

Segment by Application

BY REGION

BY COMPANY

FEATURED COMPANIES